Greg Caressi is the global business unit leader for the Transformational Health practice at Frost & Sullivan, leading research, consulting and sales teams across the Digital Health, Pharma 2.0, Next Generation Diagnostics, Medical Devices and Medical Imaging & Informatics programs. In addition to his leadership responsibilities, Greg spends much of his time working on strategic consulting projects on next-generation healthcare solutions, drawing insights from interactions with healthcare providers, payors, medtech vendors and other healthcare stakeholders.
Greg served for two years as the Chair of the HIMSS Life Sciences Information Technology Committee, where he led the creation of industry guidance for Good Informatics Practices used by life science companies, from startups to major pharmaceutical companies.
Greg regularly serves as chair, speaker and leader of interactive workshops at major industry events in the U.S., Asia, and Latin America. Recent workshops have focused on digital transformation of medtech companies, developing a next-generation patient engagement platform and marketing and competitive intelligence strategy planning for new product launches.